$1,499.00
Quantity: ~1M viable cells
CIRM Line ID: CW20090
Disease: Autism Spectrum Disorder
Gender: Female
Sampled age: 18
Ethinicity: Asian
Description
Quantity: ~1M viable cells
CIRM Line ID: CW20090
Disease: Autism Spectrum Disorder
Gender: Female
Sampled age: 18
Race: Asian
Donor data
Demographic (source: CIRM) | Description | AUTISM SPECTRUM DISORDER; ASD |
Affected Status | Yes | |
Product | iPSC | |
Source | PBMC | |
Sex | Female | |
Age at Sampling | 18 YR | |
Race | Asian | |
Ethnicity | Not Hispanic or Latino | |
Publications Cited | 0 | |
dbGap | No | |
Diagnosis Age | 3 | |
Biopsy Source | Blood | |
Collection | Neurodevelopmental Disorders | |
Cell Type | Stem Cell | |
Tissue Type | Induced pluripotent stem cell | |
Transformant | Episomal | |
Species | sapiens | |
Common Name | human | |
Detailed Clinical Data | false | |
Clinical data (source: CIRM) | ASD | ASD |
Number_of_siblings_with_ASD | 0 | |
Symptoms_Present_in_the_First_Year_of_Life | No data | |
Communication_-_Verbal | 20 | |
Communication_-_Nonverbal | 12 | |
Restricted_Repetitive_and_Stereotyped_Patterns_of_ | 6 | |
Abnormality_of_Development_Evident_at_or_Before_36 | 4 | |
Qualitative_Impairment_in_Reciprocal_Social_Intera | 29 | |
ADOS_Test_Used | ADOS 2 | |
Communication_and_Social | 13 | |
Stereotyped_Behaviors_and_Restricted_Interests | 5 | |
Full_Scale_IQ | 40 | |
Verbal_IQ | 43 | |
Non_Verbal_IQ | 40 | |
Test_used | Stanford Binet | |
ASDMedicalFamilyHistory | ASDMedicalFamilyHistory | |
Diagnosis | Autism Spectrum Disorder | |
Birthweight_(kgs) | 3.88 | |
Birth_order | 2 | |
Number_of_siblings_(includes_half_and_whole_siblin | 1 | |
Weight_% | 50 | |
Height_% | 55.88 | |
Head_Circumference_(cm) | 59 | |
Maternal_age_(years) | 54 | |
Maternal_age_at_delivery_(years) | 36 | |
Paternal_age_(years) | 59 | |
Paternal_age_at_delivery_(years) | 41 | |
Chromosome_test_results | Not Available | |
Consanguinity | No |
- Users do not need any additional license for the use of these differentiated cells even when cells are used for high throughput screening or drug discovery.
- All donor consents include statements on the following:
- Testing the cells’ DNA (this is referred to as the cell’s genetic code or sequence) and making the information known to other researchers
- Changing some of the genetic code or sequence within these cells
- Using cells to test or select drugs to treat disease
- Transplanting cells or resulting products to humans or animals
Distributing cells widely (nationally and internationally) for research, training or commercial medical product development
- Future research and uses unforeseen at this time
- Donors were screened and negative for HIV, HBV, and HCV. Donors under the age of 18 could opt out of HIV testing; all HCV-positive donors submitted skin punches, not peripheral blood, and were not screened for any infectious agents due to small volume of blood present in punches.
- Human induced pluripotent stem cells were established by non-integrating episomal reprogramming. Reprogramming and quality control were performed by Cellular Dynamics International.
Characteristics
Please refer this page for some characteristics data.